Jeffrey H. Murray

Array ( [id] => 5392223 [patent_doc_number] => 20090209536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'AMINOQUINAZOLINE CANNABINOID RECEPTOR MODULATORS FOR TREATMENT OF DISEASE' [patent_app_type] => utility [patent_app_number] => 12/140033 [patent_app_country] => US [patent_app_date] => 2008-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58465 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209536.pdf [firstpage_image] =>[orig_patent_app_number] => 12140033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212301 [patent_doc_number] => 20110135601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'BICYCLOANILINE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/663729 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66520 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135601.pdf [firstpage_image] =>[orig_patent_app_number] => 12663729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4760029 [patent_doc_number] => 20080312255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'PIPERDINE COMPOUNDS AND USES THEREOF-911' [patent_app_type] => utility [patent_app_number] => 12/136884 [patent_app_country] => US [patent_app_date] => 2008-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45733 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312255.pdf [firstpage_image] =>[orig_patent_app_number] => 12136884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8375363 [patent_doc_number] => 08258152 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'N-substituted azaindoles and methods of use' [patent_app_type] => utility [patent_app_number] => 12/664303 [patent_app_country] => US [patent_app_date] => 2008-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16788 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12664303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9086401 [patent_doc_number] => 08557830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'RAF kinase modulators and methods of use' [patent_app_type] => utility [patent_app_number] => 12/663504 [patent_app_country] => US [patent_app_date] => 2008-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36782 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12663504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772477 [patent_doc_number] => 08426432 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties' [patent_app_type] => utility [patent_app_number] => 12/133099 [patent_app_country] => US [patent_app_date] => 2008-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 25057 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12133099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720178 [patent_doc_number] => 20080242701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Novel Compounds And Methods Of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/132254 [patent_app_country] => US [patent_app_date] => 2008-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16821 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242701.pdf [firstpage_image] =>[orig_patent_app_number] => 12132254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6422699 [patent_doc_number] => 20100167931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'HETEROCYCLICALLY SUBSTITUTED HETEROCYCLYLCARBOXYLIC ACID DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/663218 [patent_app_country] => US [patent_app_date] => 2008-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33658 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167931.pdf [firstpage_image] =>[orig_patent_app_number] => 12663218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527848 [patent_doc_number] => 08304418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Pyrazolopyrimidinone kinase inhibitor' [patent_app_type] => utility [patent_app_number] => 12/602021 [patent_app_country] => US [patent_app_date] => 2008-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20587 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12602021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5415833 [patent_doc_number] => 20090041720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'HETEROARYL SUBSTITUTED THIAZOLES' [patent_app_type] => utility [patent_app_number] => 12/125554 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24759 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041720.pdf [firstpage_image] =>[orig_patent_app_number] => 12125554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5417210 [patent_doc_number] => 20090043097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Methods' [patent_app_type] => utility [patent_app_number] => 12/121228 [patent_app_country] => US [patent_app_date] => 2008-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5461 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20090043097.pdf [firstpage_image] =>[orig_patent_app_number] => 12121228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4553353 [patent_doc_number] => 07820666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Tetrahydrotriazolopyrazine derivatives and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/116475 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9494 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820666.pdf [firstpage_image] =>[orig_patent_app_number] => 12116475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740637 [patent_doc_number] => 20080234290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'NEW INDOLE OR BENZIMIDAZOLE DERIVATIVES AS CB1 INVERSE AGONISTS' [patent_app_type] => utility [patent_app_number] => 12/114219 [patent_app_country] => US [patent_app_date] => 2008-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25286 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234290.pdf [firstpage_image] =>[orig_patent_app_number] => 12114219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792739 [patent_doc_number] => 20080293713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme' [patent_app_type] => utility [patent_app_number] => 12/112643 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31075 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293713.pdf [firstpage_image] =>[orig_patent_app_number] => 12112643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792790 [patent_doc_number] => 20080293764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'LPA RECEPTOR ANTAGONIST' [patent_app_type] => utility [patent_app_number] => 12/112563 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63727 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293764.pdf [firstpage_image] =>[orig_patent_app_number] => 12112563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310774 [patent_doc_number] => 20090018055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => '[6,5]-BICYCLIC GPR119 G PROTEIN-COUPLED RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 12/112053 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28811 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018055.pdf [firstpage_image] =>[orig_patent_app_number] => 12112053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515471 [patent_doc_number] => 20090215778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Alpha-substituted Arylmethyl Piperazine Pyrazolo [1,5-alpha]Pyrimidine Amide Derivatives' [patent_app_type] => utility [patent_app_number] => 12/149178 [patent_app_country] => US [patent_app_date] => 2008-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83148 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215778.pdf [firstpage_image] =>[orig_patent_app_number] => 12149178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527844 [patent_doc_number] => 08304414 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Pyrazole compounds useful as protein kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/109598 [patent_app_country] => US [patent_app_date] => 2008-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18807 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12109598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4726622 [patent_doc_number] => 20080206163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Derivatives of pyrimido[6, 1-A]isoquinolin-4-one' [patent_app_type] => utility [patent_app_number] => 12/150232 [patent_app_country] => US [patent_app_date] => 2008-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13544 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206163.pdf [firstpage_image] =>[orig_patent_app_number] => 12150232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8232841 [patent_doc_number] => 08198281 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Crystalline forms of dihydropyrazolopyrimidinone' [patent_app_type] => utility [patent_app_number] => 12/597012 [patent_app_country] => US [patent_app_date] => 2008-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 16941 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198281.pdf [firstpage_image] =>[orig_patent_app_number] => 12597012 [rel_patent_id] =>[rel_patent_doc_number] =>)